Addex Therapeutics to Present at the Thirteenth London International Cough Symposium (13th LICS) Read More » July 12, 2024
Medsenic, a Subsidiary of BioSenic SA, Extends Key Patent to the United States Read More » July 5, 2024
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ ® Read More » July 1, 2024
Bio-Rad Launches Celselect Slides 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research Read More » June 27, 2024
PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera Read More » June 25, 2024